Life Amia is an acronym for the EU-funded, international engineering project ref. LIFE18 ENV/ES/000170 aiming to develop a novel approach to wastewater treatment by implementing a combination of carbon-neutral emerging technologies in a fully functional, mid-size (<3000 m3/day) demonstration plant located in the region of Murcia, Spain. A local company based in Runcorn, specializing in water purification systems, Arvia Technology Ltd, was awarded with the prestigious contract to develop an economical, reliable, environmentally considerate, off-grid solution for the destruction of micro-organics and pathogens in water and wastewater utilising solar energy for the Life Amia project. The developed technology is expected to improve the feasibility and economics of domestic and industrial water reuse in geographically remote locations. To achieve this, the project aimed to determine the optimal means of powering an Arvia Technology Ltd electrochemical water treatment reactor using solar photovoltaic panels.
The goal of this presentation is to provide a comprehensive summary of research results and a synopsis of key findings of the MRes study on the feasibility of using photovoltaic technology to power Arvia Technology Ltd electrochemical reactor. The research was focused on the specification, design, construction, characterisation and demonstration of a laboratory scale, solar-powered, prototype and determined the basic design rules for product scale-up. The findings provided a clear answer to an important question: whether it is possible to mitigate water scarcity and water poverty by implementation of low-cost electrochemical water purification systems powered by solar energy.
Arvia Technology is proud of the contributions made to water industry. The company is very excited about this new opportunity and is looking forward to installing a scaled-up, solar-powered, water purification system at the Life Amia plant.
Robert is an MRes student at the Faculty of Science and Engineering, University of Chester, under the supervision of Dr Bin Yang and Dr David Ward.